Search

You searched for "retinitis"

809 results found
Ophthalmic Plastic and Reconstructive Surgery journal front cover image.

Inverted papilloma

3 June 2021 | | EYE - Oculoplastic, EYE - Orbit
This is a retrospective review of 22 patients with inverted papilloma, including nine cases confined to the nasolacrimal system and 13 involving into the orbit. This is a rare disease and the report is the largest published series of periocular...
Ophthalmologica journal cover image

Update: Non-infectious retinal vasculitis

2 December 2024 | | EYE - Vitreo-Retinal
This review article summarises the update on non-infectious retinal vasculitis (RV). It is primarily classified based on the type of retinal vessels involved and further sub-classified as occlusive or nonocclusive. Clinically it can occur as an isolated ocular entity or...

Progress in retinal disease management: Highlights of the Retina Day, RCOphth 2025 Annual Congress

4 August 2025 | | EYE - Vitreo-Retinal
The Retina Day meeting at the Royal College of Ophthalmologists (RCOphth) 2025 Annual Congress in Liverpool was held on 22 May 2025. This report highlights 10 selected topics of interest to subspecialists and general ophthalmologists. Decarbonising anti-VEGF clinics (or making...

Intraocular surgery and dry eye: Understanding the link, minimising the risk and preparing for the future

11 June 2026 | | EYE - Cornea, EYE - Cataract
Dry eye disease (DED) and ocular surface disease (OSD) are increasingly recognised as central factors in contemporary intraocular surgery. As cataract, glaucoma and vitreoretinal procedures advance toward greater refractive precision, patient expectations have risen and tolerance for postoperative visual fluctuation...

Four pillars: The importance of clinical research

2 October 2025 | | EYE - General
This series explores the four pillars of advanced clinical practice and here, Rebecca Turner explores the pillar of clinical research. The role of the ophthalmic advanced nurse practitioner, as with all registered practitioners allied to ophthalmology, is on an upward...

An interview with Professor John Forrester

2 December 2019 | | EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...

In conversation with John Forrester

2 December 2019 | | EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...

Part 2: Good news, bad news at the international conference

2 August 2024 | | EYE - General
In the second instalment of this two-part article (click here for Part 1), our editor Peter Cackett presents the ‘good news’ and ‘bad news’ from an international conference experience. Readers will remember that in the last issue I left you...

Cataract surgery in corneal disease

3 June 2026 | | EYE - Cornea, EYE - Cataract
Cataract surgery in the presence of corneal disease presents multiple challenges, from determining whether symptoms are lenticular or corneal in origin, to decisions regarding timing of surgery, intraocular lens (IOL) power calculation, IOL selection, surgical technique and perioperative care. Realistic...

The Global Vision Database

1 December 2015 | | EYE - General
The overall goal of the Global Vision Database (GVD) [1] is to develop and deploy new and improved evidence on the prevalence of blindness and vision impairment (VI) globally. It is a repository which allows us to assess the causes...

Proning and the pandemic - ocular complications seen in critical care

6 April 2021 | | EYE - Vitreo-Retinal, EYE - Orbit, EYE - Cornea, EYE - General
Priyanka Sanghi and her co-authors explore the ocular complications seen in critical care units throughout the country as we treat patients through this challenging time. The SARS-Cov-2 (COVID-19) pandemic has placed the NHS and critical care services under immense strain,...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...